Trial Profile
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 20 Jun 2018
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 27 Aug 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 27 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2008 New trial record.